SERCA PHARMACEUTICALS AS
Signals
- Driftsunderskudd 2024 Siste driftsresultat er negativt (−1,5 mill kr).
- Nylig endring 2026-07-21 Aksjekapital registrert 2026-07-21.
SERCA PHARMACEUTICALS AS is registered as a limited company in Oslo, Oslo with organisation number 921663846. The business is classified under research and experimental development on natural sciences and engineering (NACE 72.100). The company was incorporated in 2018. Registered share capital is NOK 896,000, divided into 895550 shares. The company's stated purpose is: “Utvikle, markedsføre og selge medisinske produkter og utstyr, samt det som står i forbindelse med dette.”. The most recent filed accounts, for the 2024 financial year, show NOK 4.7m in revenue and NOK −1.5m in operating profit.
Key figures · 2024
Financial health · 2024
Who owns SERCA PHARMACEUTICALS AS?
SERCA PHARMACEUTICALS AS has 16 registered shareholders:
- SARSIA SEED FOND II AS 40.4%
- INVEN2 AS 26.1%
- SATURN INVEST AS 10.9%
- MP PENSJON PK 9.1%
- HERSETH AS 4.5%
- K OG K AS 2.6%
- IFH CONSULTING AS 2.5%
- KJETIL TASKEN 0.8%
- KRISTIN SANDEREID 0.6%
- TORBJØRN LEIV ØYE 0.5%
- BIRGITTE LYGREN 0.5%
- ELLEN ØSTENSEN 0.4%
- ANA ISABEL COSTA CALEJO 0.4%
- DRUG DISCOVERY LABORATORY AS 0.3%
- IVAR SJAASTAD 0.2%
- JAN MAGNUS ARONSEN 0.1%
Frequently asked questions about SERCA PHARMACEUTICALS AS
Who owns SERCA PHARMACEUTICALS AS?
SARSIA SEED FOND II AS is the largest registered owner, with 40.4%.
What is the revenue of SERCA PHARMACEUTICALS AS?
SERCA PHARMACEUTICALS AS had revenue of NOK 4.7m in 2024.
Who is the general manager of SERCA PHARMACEUTICALS AS?
Kjetil Hestdal is registered as general manager of SERCA PHARMACEUTICALS AS.
Where is SERCA PHARMACEUTICALS AS based?
SERCA PHARMACEUTICALS AS has its business address in Oslo.
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.